Identification and RT-qPCR Validation of Biomarkers Based on Butyrate Metabolism-Related Genes to Predict Recurrent Miscarriage
Wei Wang,Haobo Chen,Qiaochu Zhou
DOI: https://doi.org/10.2147/jir.s470087
IF: 4.5
2024-10-01
Journal of Inflammation Research
Abstract:Wei Wang, 1 Haobo Chen, 1, &ast Qiaochu Zhou 2, &ast 1 Department of Gynecology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, Zhejiang, People's Republic of China; 2 Department of Dermatology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, Zhejiang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Haobo Chen, Department of Gynecology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, 75 Jinxiu Road Lucheng District, Wenzhou, Zhejiang, 325000, People's Republic of China, Email Qiaochu Zhou, Department of Dermatology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, 75 Jinxiu Road Lucheng District, Wenzhou, Zhejiang, 325000, People's Republic of China, Email Purpose: To date, the cause of recurrent miscarriage (RM) in at least 50% of patients remains unknown. However, no study has explored the correlation between butyrate metabolism-related genes (BMRGs) and RM. Methods: RM-related datasets (GSE165004, GSE111974, GSE73025, and GSE179996) were obtained from the Gene Expression Omnibus (GEO) database. First, 595 differentially expressed genes (DEGs) were identified between the RM and control samples in GSE165004. Subsequently, 213 differentially expressed BMRGs (DE-BMRGs) were identified by considering the intersection of DEGs with BMRGs. The protein-protein interaction (PPI)network of DE-BMRGs contained 156 nodes and 250 edges, and a key module was obtained. In total, four biomarkers (ACTR2, ANXA2, PFN1, and OAS1) were acquired through least absolute shrinkage and selection operator (LASSO), support vector machine-recursive feature elimination (SVM-RFE), and random forest (RF). Immune analysis revealed two immune cells and three immune-related gene sets that were significantly different between the RM and control groups, namely, T helper cells, regulatory T cells (Treg), MHC class I, parainflammation, and type I IFN response. In addition, a TF-mRNA network based on the top 100 nodes ranked in the order of connectivity was created, including 100 nodes and 253 edges, such as MTERF2-ACTR2, NKX23-PFN1, STAT1-OAS1, and SP100-ANXA2. Results: Finally, 3 drugs (withaferin A, N-ethylmaleimide, and etoposide) were predicted to interact with 2 biomarkers (ANXA2 and ACTR2). Eventually, ANXA2 and OAS1 were significantly downregulated, and PFN1 was markedly overexpressed in the RM group, as determined by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Conclusion: Our findings authenticated four butyrate metabolism-related biomarkers for the diagnosis of RM, providing a scientific reference for further studies on RM treatment. Keywords: recurrent miscarriages, butyrate metabolism, biomarkers, bioinformatics analysis Miscarriage is one of the most prevalent complications of pregnancy, occurring in 15.3% of all clinically recognized pregnancies. Recurrent miscarriage (RM) is frustrating for clinicians and heartbreaking for patients. Approximately 1.9% (1.8−2.1%) and 0.7% (0.5−0.8%) of women experience two and three or more miscarriages, respectively. 1 Miscarriage is known to be associated with several etiological factors, including chromosomal abnormalities in couples or embryos, anatomical factors in the reproductive organs, endocrine abnormalities, endometrial dysfunction, infectious factors, and thrombophilia. Nevertheless, the etiology of this disease remains an enigma in up to 50% of cases 2 and requires in-depth etiopathogenesis studies. Given that successful pregnancy involves multiple maternal physiological changes and the intricate interactions between the fetus and mother, researchers have concentrated on the relationship between miscarriage and chromosomal abnormalities or maternal-fetal interface imbalance. Decidualization refers to the optimal transformation of endometrial stromal cells (ESCs) after embryo implantation, which is vital for establishing pregnancy in humans. Throughout pregnancy, immune responses are carefully regulated to balance antimicrobial protection for both the mother and fetus with the necessity for immune tolerance to prevent fetal rejection. 3 Accordingly, the maternal-fetal interface, represented by the uterine decidua, harbors diverse populations of immune cells capable of performing various functions throughout the gestational period. Gut microbiota is largely accountable for balancing host defense and immune tolerance. 4 Butyrate is a specific short-chain fatty acid (SCFA) that is readily generated by microbial fermentation from fiber-rich diets, which plays a crucial role in sustainin -Abstract Truncated-
immunology